Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | GALR1 | P47211 | 1/20 | 0.31 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | USP7 | Q93009 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.30 |
| ▸ | ADCY10 | Q96PN6 | 1/20 | 0.30 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016980 | 0.79 | SMN1; SMN2 (0.38) | L3MBTL1GALR1FGFR3PIK3CASMN1; SMN2 | |
| SCHEMBL5555659 | 0.79 | PDGFRB (0.32) | GALR1PIK3CALTC4S | |
| SCHEMBL6612950 | 0.75 | DRD2 (0.33) | SMN1; SMN2LMNA | |
| SCHEMBL6232918 | 0.73 | GALR1 (0.37) | L3MBTL1ALDH1A1GALR1PIK3CASMN1; SMN2 | |
| SCHEMBL5032177 | 0.73 | KDM4E (0.40) | L3MBTL1ALDH1A1MAPK1GALR1SMN1; SMN2 | |
| SCHEMBL6231085 | 0.72 | DRD2 (0.36) | L3MBTL1ALDH1A1NPC1MAPK1SMN1; SMN2 | |
| SCHEMBL6428170 | 0.71 | GALR1 (0.37) | CDK2L3MBTL1ALDH1A1MAPK1GALR1 | |
| SCHEMBL6819109 | 0.71 | LMNA (0.45) | ALDH1A1MAPK1FGFR3PIK3CASMN1; SMN2 | |
| SCHEMBL4840755 | 0.70 | GALR1 (0.56) | CCNA2CDK2CCNA1L3MBTL1GALR1 | |
| SCHEMBL6233028 | 0.70 | CYP19A1 (0.41) | GALR1PIK3CASMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040209882-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-10-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209882-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | CCNA2 1204/4885CDK2 606/4885CCNA1 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.